The Journal of Infectious Diseases · 1999 · 94 citations · 13 references
Life SciencesImmunologyMicrobiologyHost-pathogen InteractionsInnate ImmunityMycologyAntifungal AgentsAntifungal TherapyFungal ImmunologyFungal InfectionsFungal PathogenesisOpportunistic InfectionsCandida Albicans InfectionCellular Immune Response To FungiFungal Immune PrimingHost Immune Response ModulationHost Immune Response To FungiInterferon-mediated Antifungal ResponsesNeutrophil Antifungal ResponsesOpportunistic Fungal Infections
Proinflammatory cytokines have been proposed as adjunctive therapeutic agents to enhance the host immune response during infections caused by opportunistic fungi. The study compared the differential in vitro priming effects of interferon-gamma (IFN-gamma), granulocyte colony-stimulating factor (G-CSF), and granulocyte-macrophage colony-stimulating factor (GM-CSF) on hyphal damage of opportunistic fungi mediated by isolated neutrophils (polymorphonuclear leukocytes, PMNL) and buffy coat cells (polymorphonuclear leukocytes/peripheral blood mononuclear cells, PMNL/PBMC) from healthy donors. IFN-gamma (1000 U/mL) effectively primed both PMNL and PMNL/PBMC for enhanced hyphal damage of Aspergillus fumigatus, Fusarium solani, and Candida albicans. G-CSF (100 ng/mL) increased hyphal damage mediated by both PMNL and PMNL/PBMC against F. solani, and GM-CSF (100 ng/mL) augmented the antifungal activity of PMNL/PBMC against hyphal forms of both F. solani and C. albicans. IFN-gamma may be superior to G-CSF or GM-CSF for enhancing the microbicidal activity of PMNL and PMNL/PBMC against opportunistic fungi.
13
Emmanuel Roilides, K Uhlig, David Venzon et al. · Infection and Immunity · 1993 · 211 citations · Full text
Stuart M. Levitz, Michael E. Selsted, Tomas Ganz et al. · The Journal of Infectious Diseases · 1986 · 196 citations
Tova Meshulam, Stuart M. Levitz, Laurent Christin et al. · The Journal of Infectious Diseases · 1995 · 190 citations